Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer

Cancer Res. 2003 Apr 1;63(7):1652-6.

Abstract

Current diagnostic and therapeutic strategies for lung cancer have had no significant impact on lung cancer mortality over the last several decades. This study used a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) discovery platform to generate protein expression profiles in search of overexpressed proteins in lung tumors as potentially novel molecular targets. Two differentially expressed protein peaks at m/z 12338 and 17882 in the MALDI-TOF spectra were identified in lung tumor specimens as macrophage migration inhibitory factor and cyclophilin A, respectively. Overexpression of both proteins was confirmed by Western blotting, and cyclophilin A was localized to the tumor cells by immunohistochemistry. These data demonstrate the feasibility of using a MALDI-TOF platform to generate protein expression profiles and identify potential molecular targets for cancer diagnostics and therapeutics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Carcinoma, Non-Small-Cell Lung / genetics
  • Carcinoma, Non-Small-Cell Lung / metabolism*
  • Cyclophilin A / biosynthesis*
  • Cyclophilin A / genetics
  • Gene Expression Profiling
  • Humans
  • Immunoblotting
  • Immunohistochemistry
  • Lung Neoplasms / genetics
  • Lung Neoplasms / metabolism*
  • Macrophage Migration-Inhibitory Factors / biosynthesis*
  • Macrophage Migration-Inhibitory Factors / genetics
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Peptide Mapping
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Substances

  • Macrophage Migration-Inhibitory Factors
  • Cyclophilin A